The results of the present study showed that in comparison with the fatty liver groups, the combination therapy group (NAFLD+LGG+HIIT) caused a significant decrease in TIMP-1 mRNA compared to the NAFLD group. The gene discussed is TIMP1; the disease is metabolic dysfunction-associated steatotic liver disease.